Products billed under this code include Cefazolin Sodium, Cefazolin Sodium in Dextrose.
Payment limit per 500 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Cefazolin Sodium | Hikma Pharmaceuticals USA Inc. | 00143-9261-10 | 200 | $156.20 |
| Cefazolin Sodium | Hikma Pharmaceuticals USA Inc. | 00143-9262-25 | 50 | $39.05 |
| Cefazolin Sodium | Hikma Pharmaceuticals USA Inc. | 00143-9923-90 | 25 | $19.525 |
| Cefazolin Sodium | Hikma Pharmaceuticals USA Inc. | 00143-9924-90 | 50 | $39.05 |
| Cefazolin Sodium | Hikma Pharmaceuticals USA Inc. | 00143-9983-03 | 200 | $156.20 |
| Cefazolin Sodium | Henry Schein Inc. | 00404-9833-99 | 2 | $1.562 |
| Cefazolin Sodium | Henry Schein Inc. | 00404-9834-99 | 2 | $1.562 |
| Cefazolin Sodium | Henry Schein Inc. | 00404-9835-99 | 1 | $0.781 |
| Cefazolin Sodium | Pfizer Inc | 00409-2585-01 | 50 | $39.05 |
| Cefazolin Sodium | Sandoz Inc. | 00781-3450-95 | 10 | $7.81 |
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Cefazolin Sodium | Sandoz Inc. | 00781-3451-95 | 20 | $15.62 |
| Cefazolin Sodium | Sandoz Inc. | 00781-3451-96 | 50 | $39.05 |
| Cefazolin Sodium | Sandoz Inc. | 00781-3452-95 | 200 | $156.20 |
| Cefazolin Sodium | Sagent Pharmaceuticals | 25021-0100-10 | 25 | $19.525 |
| Cefazolin Sodium | Sagent Pharmaceuticals | 25021-0100-66 | 25 | $19.525 |
| Cefazolin Sodium | Sagent Pharmaceuticals | 25021-0101-10 | 50 | $39.05 |
| Cefazolin Sodium | Sagent Pharmaceuticals | 25021-0101-67 | 50 | $39.05 |
| Cefazolin Sodium | Sagent Pharmaceuticals | 25021-0102-69 | 200 | $156.20 |
| Cefazolin Sodium | Sagent Pharmaceuticals | 25021-0102-99 | 200 | $156.20 |
| Cefazolin Sodium | WG Critical Care, LLC | 44567-0120-25 | 50 | $39.05 |
| Cefazolin Sodium | WG Critical Care, LLC | 44567-0706-25 | 25 | $19.525 |
| Cefazolin Sodium | WG Critical Care, LLC | 44567-0707-25 | 50 | $39.05 |
| Cefazolin Sodium | WG Critical Care, LLC | 44567-0708-10 | 200 | $156.20 |
| Cefazolin Sodium | A-S Medication Solutions | 50090-4256-00 | 50 | $39.05 |
| Cefazolin Sodium | Apotex Corp | 60505-6142-05 | 50 | $39.05 |
| Cefazolin Sodium | Apotex Corp | 60505-6143-04 | 200 | $156.20 |
| Cefazolin Sodium | Apotex Corp | 60505-6231-05 | 100 | $78.10 |
| Cefazolin Sodium | Apotex Corp | 60505-6243-04 | 50 | $39.05 |
| Cefazolin Sodium | Apotex Corp | 60505-6244-04 | 200 | $156.20 |
| Cefazolin Sodium | Apotex Corp | 60505-6266-05 | 150 | $117.15 |
| Cefazolin Sodium | FreseniUS Kabi USA, LLC | 63323-0237-10 | 50 | $39.05 |
| Cefazolin Sodium | FreseniUS Kabi USA, LLC | 63323-0238-61 | 200 | $156.20 |
| Cefazolin Sodium | Civica, Inc. | 72572-0055-25 | 50 | $39.05 |
| Cefazolin Sodium | Civica, Inc. | 72572-0056-10 | 200 | $156.20 |
| Cefazolin Sodium in Dextrose | B. Braun Medical Inc. | 00264-3103-11 | 48 | $37.488 |
| Cefazolin Sodium in Dextrose | B. Braun Medical Inc. | 00264-3105-11 | 96 | $74.976 |
| Cefazolin Sodium in Dextrose | B. Braun Medical Inc. | 00264-3107-11 | 144 | $112.464 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $0.781 | −$0.015 | 500 MG | Cefazolin sodium injection | v1, posted September 17, 2026 |
| 3Q26 | $0.796 | −$0.049 | 500 MG | Cefazolin sodium injection | v1, posted September 15, 2026 |
| 2Q26 | $0.845 | +$0.018 | 500 MG | Cefazolin sodium injection | v1, posted September 15, 2026 |
| 1Q26 | $0.827 | +$0.029 | 500 MG | Cefazolin sodium injection | v1, posted September 15, 2026 |
| 4Q25 | $0.798 | −$0.037 | 500 MG | Cefazolin sodium injection | v1, posted September 8, 2026 |
| 3Q25 | $0.835 | +$0.007 | 500 MG | Cefazolin sodium injection | v1, posted March 10, 2026 |
| 2Q25 | $0.828 | +$0.014 | 500 MG | Cefazolin sodium injection | v1, posted March 10, 2026 |
| 1Q25 | $0.814 | +$0.009 | 500 MG | Cefazolin sodium injection | v1, posted December 19, 2025 |
| 4Q24 | $0.805 | −$0.012 | 500 MG | Cefazolin sodium injection | v1, posted June 11, 2025 |
| 3Q24 | $0.817 | +$0.002 | 500 MG | Cefazolin sodium injection | v1, posted June 11, 2025 |
| 2Q24 | $0.815 | +$0.052 | 500 MG | Cefazolin sodium injection | v1, posted March 11, 2025 |
| 1Q24 | $0.763 | +$0.036 | 500 MG | Cefazolin sodium injection | v1, posted December 19, 2024 |
| 4Q23 | $0.727 | −$0.142 | 500 MG | Cefazolin sodium injection | v1, posted October 10, 2024 |
| 3Q23 | $0.869 | +$0.102 | 500 MG | Cefazolin sodium injection | v1, posted June 5, 2024 |
| 2Q23 | $0.767 | +$0.037 | 500 MG | Cefazolin sodium injection | v1, posted February 23, 2024 |
| 1Q23 | $0.73 | +$0.01 | 500 MG | Cefazolin sodium injection | v1, posted December 6, 2023 |
| 4Q22 | $0.72 | −$0.035 | 500 MG | Cefazolin sodium injection | v1, posted June 22, 2023 |
| 3Q22 | $0.755 | +$0.095 | 500 MG | Cefazolin sodium injection | v1, posted June 9, 2023 |
| 2Q22 | $0.66 | −$0.109 | 500 MG | Cefazolin sodium injection | v1, posted December 14, 2022 |
| 1Q22 | $0.769 | +$0.023 | 500 MG | Cefazolin sodium injection | v1, posted June 8, 2022 |
| 4Q21 | $0.746 | −$0.051 | 500 MG | Cefazolin sodium injection | v1, posted June 2, 2022 |
| 3Q21 | $0.797 | −$0.027 | 500 MG | Cefazolin sodium injection | v1, posted June 2, 2022 |
| 2Q21 | $0.824 | +$0.004 | 500 MG | Cefazolin sodium injection | v1, posted March 1, 2022 |
| 1Q21 | $0.82 | – | 500 MG | Cefazolin sodium injection | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.
